Search research articles
Contact Us
Filters
Showing results (131-140 of 147) with videos related to
Page
of 15
Sort By:
Oncogene
|
March 26, 2014
Slug is temporally regulated by cyclin E in cell cycle and controls genome stability
W-L Wang, H-C Huang, S-H Kao, et al.
The American Journal of Pathology
|
May 22, 2003
Mutation of p53 in recurrent hepatocellular carcinoma and its association with the expression of ZBP-89
George G Chen, Juanita L Merchant, Paul B S Lai, et al.
Emerging Infectious Diseases
|
June 22, 2022
Natural Reassortment of Eurasian Avian-Like Swine H1N1 and Avian H9N2 Influenza Viruses in Pigs, China
Wanying Sun, Samuel S M Cheng, Kristy N T Lam, et al.
Epidemiology and Infection
|
November 28, 2017
Impact of an intervention programme on knowledge, attitudes and practices of population regarding severe fever with thrombocytopenia syndrome in endemic areas of Lu'an, China
Y Lyu, C-Y Hu, L Sun, et al.
The Journal of Infectious Diseases
|
September 15, 2022
Slow Waning of Antibodies Following BNT162b2 as a Third Dose in Adults Who Had Previously Received 2 Doses of Inactivated Vaccine
Benjamin J Cowling, Samuel M S Cheng, Mario Martín-Sánchez, et al.
Arthritis and Rheumatism
|
October 2, 2007
International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials
Lucy R Wedderburn, Hemlata Varsani, Charles K C Li, et al.
Vaccine
|
September 14, 2024
Durability for 12 months of antibody response to a booster dose of monovalent BNT162b2 in adults who had initially received 2 doses of inactivated vaccine
Eunice Y C Shiu, Samuel M S Cheng, Mario Martín-Sánchez, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics
|
February 27, 2023
[Analysis of risk factors of mortality in infants and toddlers with moderate to severe pediatric acute respiratory distress syndrome]
B L Fang, F Xu, G P Lu, et al.
Nature Medicine
|
January 20, 2022
Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination
Samuel M S Cheng, Chris Ka Pun Mok, Yonna W Y Leung, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 8, 2022
Immunogenicity of a Third Dose of BNT162b2 to Ancestral Severe Acute Respiratory Syndrome Coronavirus 2 and the Omicron Variant in Adults Who Received 2 Doses of Inactivated Vaccine
Nancy H L Leung, Samuel M S Cheng, Mario Martín-Sánchez, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 147) with videos related to
Sort By:
Page
of 15
Oncogene
|
March 26, 2014
Slug is temporally regulated by cyclin E in cell cycle and controls genome stability
W-L Wang, H-C Huang, S-H Kao, et al.
The American Journal of Pathology
|
May 22, 2003
Mutation of p53 in recurrent hepatocellular carcinoma and its association with the expression of ZBP-89
George G Chen, Juanita L Merchant, Paul B S Lai, et al.
Emerging Infectious Diseases
|
June 22, 2022
Natural Reassortment of Eurasian Avian-Like Swine H1N1 and Avian H9N2 Influenza Viruses in Pigs, China
Wanying Sun, Samuel S M Cheng, Kristy N T Lam, et al.
Epidemiology and Infection
|
November 28, 2017
Impact of an intervention programme on knowledge, attitudes and practices of population regarding severe fever with thrombocytopenia syndrome in endemic areas of Lu'an, China
Y Lyu, C-Y Hu, L Sun, et al.
The Journal of Infectious Diseases
|
September 15, 2022
Slow Waning of Antibodies Following BNT162b2 as a Third Dose in Adults Who Had Previously Received 2 Doses of Inactivated Vaccine
Benjamin J Cowling, Samuel M S Cheng, Mario Martín-Sánchez, et al.
Arthritis and Rheumatism
|
October 2, 2007
International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials
Lucy R Wedderburn, Hemlata Varsani, Charles K C Li, et al.
Vaccine
|
September 14, 2024
Durability for 12 months of antibody response to a booster dose of monovalent BNT162b2 in adults who had initially received 2 doses of inactivated vaccine
Eunice Y C Shiu, Samuel M S Cheng, Mario Martín-Sánchez, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics
|
February 27, 2023
[Analysis of risk factors of mortality in infants and toddlers with moderate to severe pediatric acute respiratory distress syndrome]
B L Fang, F Xu, G P Lu, et al.
Nature Medicine
|
January 20, 2022
Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination
Samuel M S Cheng, Chris Ka Pun Mok, Yonna W Y Leung, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 8, 2022
Immunogenicity of a Third Dose of BNT162b2 to Ancestral Severe Acute Respiratory Syndrome Coronavirus 2 and the Omicron Variant in Adults Who Received 2 Doses of Inactivated Vaccine
Nancy H L Leung, Samuel M S Cheng, Mario Martín-Sánchez, et al.
Page
of 15